1|0|Public
50|$|Psychopharmacology. Pharmaco-EEG {{studies were}} {{economically}} useful in clinically classifying new agents, dosage ranges and durations of effects, and separating active from inactive substances. The list of successful applications is extensive; some specific examples are {{the identification of}} mianserin (GB-94) and doxepin as antidepressants of the imipramine class; of the inactivity of <b>flutroline</b> as a proposed antipsychotic in man despite activity in dogs; and of equivalent EEG activity of the laevo and dextro enantiomers of 6-azamianserin (mirtazapine) despite differences in preclinical trials.|$|E

